Thomas Altman
What began as a personal journey to follow one company’s filings has become Primary Source AI—an ongoing project to turn the flood of biotech data into lasting memory.
What began as a personal journey to follow one company’s filings has become Primary Source AI—an ongoing project to turn the flood of biotech data into lasting memory.